Ligand Pharmaceuticals | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
Amgen USD 5.88B 1.65B 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
Baxter International USD 6.96B 908M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Ligand Pharmaceuticals USD 830.44M 10.74M 2024-12
MacroGenics USD 120.07M 62.25M 2024-09
Merck USD 46.31B 1.81B 2024-12
Pacira USD 778.35M 28.76M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Veracyte USD 1.18B 76K 2024-12



Ligand Pharmaceuticals Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.